Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree

Abstract

OBJECTIVE: To determine the prevalence of elevated C-reactive protein (CRP) in the Sandy Lake Oji-Cree, an aboriginal community residing in the Sioux Lookout zone of Northwestern Ontario, Canada, and to determine the associations of obesity and diabetes with CRP in a community with a very high prevalence of type II diabetes.

DESIGN: We surveyed 512 community members aged 18?y and older to determine the prevalence and the determinants of elevated CRP in Sandy Lake.

MEASUREMENTS:Clinical variables, indices of obesity and serum concentrations of CRP, insulin, serum amyloid A (SAA) and interleukin-6 (IL-6).

RESULTS: The prevalence of CRP ≥3.8?mg/l was significantly higher in women than in men (51% vs. 32%, P<0.0001). Regression analysis determined that body mass index and IL-6 were independent determinants of CRP concentration in women and waist circumference and IL-6 were independent determinants of CRP concentration in men. Diabetes was associated with elevated CRP in both sexes, but was only a moderate strong determinant in CRP concentration in multivariate regression analysis.

CONCLUSIONS: The prevalence of elevated CRP in this aboriginal community is remarkably high. These data further demonstrate that the association between CRP and specific indices of obesity and metabolism vary according to gender and glycemic status.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Blake GJ, Ridker PM . High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis. Eur Heart J 2001; 22: 349–352.

    Article  CAS  Google Scholar 

  2. Ridker PM, Hennekens CH, Buring JE, Rifai N . C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836–843.

    Article  CAS  Google Scholar 

  3. Ridker PM . High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 103: 1813–1818.

    Article  CAS  Google Scholar 

  4. Rifai N, Ridker PM . Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem 2001; 47: 28–30.

    CAS  PubMed  Google Scholar 

  5. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB . C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237–242.

    Article  CAS  Google Scholar 

  6. Meier-Ewert HK, Ridker PM, Rifai N, Price N, Dinges DF, Mullington JM . Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem 2001; 47: 426–430.

    CAS  PubMed  Google Scholar 

  7. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E . Variability and classification accuracy of serial high-sensitivity C- reactive protein measurements in healthy adults. Clin Chem 2001; 47: 444–450.

    CAS  PubMed  Google Scholar 

  8. Wener MH, Daum PR, McQuillan GM . The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration. J Rheumatol 2000; 27: 2351–2359.

    CAS  PubMed  Google Scholar 

  9. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V . Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2000; 148: 209–214.

    Article  CAS  Google Scholar 

  10. Pickup JC, Mattock MB, Chusney GD, Burt D . NIDDM as a disease of the innate immune system: association of acute- phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997; 40: 1286–1292.

    Article  CAS  Google Scholar 

  11. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW . C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972–978.

    Article  CAS  Google Scholar 

  12. Lemieux I, Pascot A, Prud'homme D, Almeras N, Bogaty P, Nadeau A, Bergeron J, Despres JP . Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001; 21: 961–967.

    Article  CAS  Google Scholar 

  13. Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner SM . Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42–47.

    Article  CAS  Google Scholar 

  14. Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T . The association of C-reactive protein serum, amyloid A and fibrinogen with prevalent coronary heart disease. Atherosclerosis 2001; 156: 451–456.

    Article  CAS  Google Scholar 

  15. Friso S, Jacques PF, Wilson PW, Rosenberg IH, Selhub J . Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation 2001; 103: 2788–2791.

    Article  CAS  Google Scholar 

  16. Harris SB, Gittelsohn J, Hanley A, Barnie A, Wolever TM,, Gao J, Logan A, Zinman B . The prevalence of NIDDM and associated risk factors in native Canadians. Diabetes Care 1997; 20: 185–187.

    Article  CAS  Google Scholar 

  17. Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Connelly PW, Zinman B . Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition. Diabetes Care 2001; 24: 1240–1247.

    Article  CAS  Google Scholar 

  18. Shah BR, Hux JE, Zinman B . Increasing rates of ischemic heart disease in the native population of Ontario, Canada. Arch Intern Med 2000; 160: 1862–1866.

    Article  CAS  Google Scholar 

  19. Harris SB, Zinman B, Hanley A, Gittelsohn J, Hegele RA, Connelly PW, Shah B, Hux JE . The impact of diabetes on cardiovascular risk factors and outcomes in a native Canadian population. Diab Res Clin Prac 2002; 55: 165–173.

    Article  Google Scholar 

  20. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197.

  21. Rifai N, Tracy RP, Ridker PM . Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999; 45: 2136–2141.

    CAS  PubMed  Google Scholar 

  22. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB . Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199–204.

    Article  CAS  Google Scholar 

  23. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM . C-reactive protein, interleukin 6, and risk of developing type II diabetes mellitus. JAMA 2001; 286: 327–334.

    Article  CAS  Google Scholar 

  24. Heilbronn LK, Noakes M, Clifton PM . Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001; 21: 968–970.

    Article  CAS  Google Scholar 

  25. Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L, Witteman J, Graham I . Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease. and coronary artery disease. European COMAC Group. Circulation 1998; 97: 437–443.

    Article  CAS  Google Scholar 

  26. Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, Hess DL, Davis CE . Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 1998; 98: 204–210.

    Article  CAS  Google Scholar 

  27. Tanaka T, Robey FA . A new sensitive assay for the calcium-dependent binding of C-reactive protein to phosphorylcholine. J Immunol Methods 1983; 65: 333–341.

    Article  CAS  Google Scholar 

  28. Carroll MC . The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol 1998; 16: 545–568.

    Article  CAS  Google Scholar 

  29. Circolo A, Garnier G, Fukuda W, Wang X, Hidvegi T, Szalai AJ, Briles DE, Volanakis JE, Wetsel RA, Colten HR . Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 1999; 42: 135–149.

    Article  CAS  Google Scholar 

  30. Kildsgaard J, Hollmann TJ, Matthews KW, Bian K, Murad F, Wetsel RA . Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol 2000; 165: 5406–5409.

    Article  CAS  Google Scholar 

  31. Albert MA, Danielson E, Rifai N, Ridker PM . Effect of statin therapy on C-reactive protein levels: The Pravastatin Inflammation/CRP Evaluation (PRINCE): A Randomized Trial and Cohort Study. JAMA 2001; 286: 64–70.

    Article  CAS  Google Scholar 

  32. Van Lenten BJ, Wagner AC, Navab M, Fogelman AM . Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6. J Biol Chem 2001; 276: 1923–1929.

    Article  CAS  Google Scholar 

  33. Cao H, Hegele RA . Human C-reactive protein (CRP) 1059G/C polymorphism. J Hum Genet 2000; 45: 100–101.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge the following groups and individuals, whose cooperation was essential in the design and implementation of this project: the chief, council and community members of Sandy Lake First Nation; the Sandy Lake community surveyors (Louisa Kakegamic, Tina Noon, Madeliene Kakegamic, and Elda Anishinabie, Annette Rae, Connie Kakegamic, Mary Mamakeesic); the Sandy Lake nurses; the staff of the University of Toronto Sioux Lookout Programme; the Department of Clinical Epidemiology of the Samuel Lunenfeld Research Institute; Dr Alexander Logan, Annette Barnie and Sasan Mohammadi-Khah. This work was supported by grants from the National Institutes of Health (91-DK-01 and 1-R21-DK-44597-01), and the Ontario Ministry of Health (#04307) and the Canadian Diabetes Association.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P W Connelly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Connelly, P., Hanley, A., Harris, S. et al. Relation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-Cree. Int J Obes 27, 347–354 (2003). https://doi.org/10.1038/sj.ijo.0802239

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0802239

Keywords

This article is cited by

Search

Quick links